These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 38604913)

  • 21. Partnering With Churches to Address COVID-19 Vaccine Hesitancy and Uptake in Trustworthy Contexts.
    Bateman LB; Hall A; Hannon L; Ryan M; Osborne T; Whitfield S; Okoro G; Stager C; Driggers S; Jones V; Rhinehart J; Fouad MN
    Am J Public Health; 2024 May; 114(S5):S392-S395. PubMed ID: 38776503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partners in vaccination: A community-based intervention to promote COVID-19 vaccination among low-income homebound and disabled adults.
    Kim SE; Turner BJ; Steinberg J; Solano L; Hoffman E; Saluja S
    Disabil Health J; 2024 Jul; 17(3):101589. PubMed ID: 38341354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
    Viswanath K; Lee EJ; Dryer E
    BMJ; 2024 Jun; 385():e076478. PubMed ID: 38901868
    [No Abstract]   [Full Text] [Related]  

  • 24. Misperceptions about routine childhood vaccination among parents in Australia, before and after the COVID-19 pandemic: a cross-sectional survey study.
    Kaufman J; Hoq M; Rhodes AL; Measey MA; Danchin MH
    Med J Aust; 2024 Jun; 220(10):530-532. PubMed ID: 38735850
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
    Chicoine N; Schnipper N; Griffin J
    PLoS One; 2024; 19(6):e0304416. PubMed ID: 38875217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causes and costs of global COVID-19 vaccine inequity.
    Ferranna M
    Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motivating COVID-19 Vaccination through Persuasive Communication: A Systematic Review of Randomized Controlled Trials.
    Xia S; Nan X
    Health Commun; 2024 Jul; 39(8):1455-1478. PubMed ID: 37254940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respecting Conversational Norms Improves Reception of Expert Messages Among Unvaccinated Individuals.
    McCrea SM; Thürmer JL; Helm MR; Erion CJ; Krueger K
    Health Commun; 2024 Aug; 39(9):1795-1806. PubMed ID: 37528775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying the impact of misinformation and vaccine-skeptical content on Facebook.
    Allen J; Watts DJ; Rand DG
    Science; 2024 May; 384(6699):eadk3451. PubMed ID: 38815040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A complex fuzzy decision model for analysing the post-pandemic immuno-sustainability.
    Pragathi S; Narayanamoorthy S; Dhivya S; Saraswathy R; Pamucar D; Simic V; Kang D
    Acta Trop; 2024 Aug; 256():107261. PubMed ID: 38772435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to Evaluate an Individual's Decision Whether to Vaccinate during a Pandemic: Better by a Knowledge Commons than by Luck Egalitarianism.
    Gregg B
    Am J Bioeth; 2024 Jul; 24(7):101-103. PubMed ID: 38913473
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 Vaccine Hesitancy Among Adolescent and Young Adult Cancer Survivors.
    Waters AR; Kepka D; Ramsay JM; Mann K; Vaca Lopez PL; Anderson JS; Ou JY; Kaddas HK; Palmer A; Ray N; Tsukamoto T; Fair DB; Lewis MA; Kirchhoff AC; Warner EL
    JNCI Cancer Spectr; 2021 Jun; 5(3):Pkab049. PubMed ID: 34195543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 vaccine hesitancy in Africa: a call to action.
    Mutombo PN; Fallah MP; Munodawafa D; Kabel A; Houeto D; Goronga T; Mweemba O; Balance G; Onya H; Kamba RS; Chipimo M; Kayembe JN; Akanmori B
    Lancet Glob Health; 2022 Mar; 10(3):e320-e321. PubMed ID: 34942117
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 vaccine acceptance and hesitancy in Indian context: a systematic review and meta-analysis.
    Dey S; Kusuma YS; Kant S; Kumar D; Gopalan RB; Sridevi P; Aggarwal S
    Pathog Glob Health; 2024 Mar; 118(2):182-195. PubMed ID: 38014567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic.
    Pitts PJ; Poland GA
    Vaccine; 2024 May; 42(13):3145-3147. PubMed ID: 38604913
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 vaccine intentions in Australia.
    Edwards B; Biddle N; Gray M; Sollis K
    Lancet Infect Dis; 2021 Dec; 21(12):1628-1629. PubMed ID: 34838220
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider?
    Arnold CG; Monte AA; Littlefield K; Vest A; Palmer BE
    Viral Immunol; 2021 Dec; 34(10):666-668. PubMed ID: 34491119
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.